University of Plymouth: Could weight loss drug benefit patients living with alcohol addiction, liver disease and obesity?
August 20, 2026
August 20, 2026
PLYMOUTH, England, Aug. 20 -- The University of Plymouth posted the following news:
* * *
Could weight loss drug benefit patients living with alcohol addiction, liver disease and obesity?
*
Scientists hope a weight loss drug already being used to treat obesity and diabetes could also benefit patients impacted by alcohol dependence and obesity, two of the biggest causes of liver disease.
Semaglutide, also known as Wegovy, works by m . . .
* * *
Could weight loss drug benefit patients living with alcohol addiction, liver disease and obesity?
*
Scientists hope a weight loss drug already being used to treat obesity and diabetes could also benefit patients impacted by alcohol dependence and obesity, two of the biggest causes of liver disease.
Semaglutide, also known as Wegovy, works by m . . .